Cargando…

Luminal membrane expression of mesothelin is a prominent poor prognostic factor for gastric cancer

BACKGROUND: Mesothelin is expressed in various types of malignant tumour, and we recently reported that expression of mesothelin was related to an unfavourable patient outcome in pancreatic ductal adenocarcinoma. In this study, we examined the clinicopathological significance of the mesothelin expre...

Descripción completa

Detalles Bibliográficos
Autores principales:	Einama, T, Homma, S, Kamachi, H, Kawamata, F, Takahashi, K, Takahashi, N, Taniguchi, M, Kamiyama, T, Furukawa, H, Matsuno, Y, Tanaka, S, Nishihara, H, Taketomi, A, Todo, S
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Nature Publishing Group 2012
Materias:	Molecular Diagnostics
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3389425/ https://www.ncbi.nlm.nih.gov/pubmed/22644300 http://dx.doi.org/10.1038/bjc.2012.235

Ejemplares similares

Importance of luminal membrane mesothelin expression in intraductal papillary mucinous neoplasms
por: EINAMA, TAKAHIRO, et al.
Publicado: (2015)

Mesothelin-Specific Immune Responses and Targeted Immunotherapy for Mesothelin-Expressing Tumors
por: Einama, Takahiro, et al.
Publicado: (2017)

High mesothelin correlates with chemoresistance and poor survival in epithelial ovarian carcinoma
por: Cheng, W-F, et al.
Publicado: (2009)

Mesothelin blockage by Amatuximab suppresses cell invasiveness, enhances gemcitabine sensitivity and regulates cancer cell stemness in mesothelin-positive pancreatic cancer cells
por: Matsuzawa, Fumihiko, et al.
Publicado: (2021)

The anti-mesothelin monoclonal antibody amatuximab enhances the anti-tumor effect of gemcitabine against mesothelin-high expressing pancreatic cancer cells in a peritoneal metastasis mouse model
por: Mizukami, Tatsuzo, et al.
Publicado: (2018)

Membrane mesothelin expression positivity is associated with poor clinical outcome of luminal-type breast cancer
por: Suzuki, Takafumi, et al.
Publicado: (2020)

Expression of N-acetylglucosaminyltransferase V in endometrial cancer correlates with poor prognosis
por: Yamamoto, E, et al.
Publicado: (2007)

Endogenous myoglobin in human breast cancer is a hallmark of luminal cancer phenotype
por: Kristiansen, G, et al.
Publicado: (2010)

Amplification of PVT-1 is involved in poor prognosis via apoptosis inhibition in colorectal cancers
por: Takahashi, Y, et al.
Publicado: (2014)

Heterogeneity of luminal breast cancer characterised by immunohistochemical expression of basal markers
por: Sung, Hyuna, et al.
Publicado: (2016)

Monitoring gastric cancer progression with circulating tumour DNA
por: Hamakawa, T, et al.
Publicado: (2015)

Serpin peptidase inhibitor clade A member 1 is a biomarker of poor prognosis in gastric cancer
por: Kwon, C H, et al.
Publicado: (2014)

Notch1 activation is a poor prognostic factor in patients with gastric cancer
por: Zhang, H, et al.
Publicado: (2014)

MYC regulation of glutamine–proline regulatory axis is key in luminal B breast cancer
por: Craze, Madeleine L, et al.
Publicado: (2018)

Overexpression of glypican-1 implicates poor prognosis and their chemoresistance in oesophageal squamous cell carcinoma
por: Hara, Hisashi, et al.
Publicado: (2016)

Expression of carbonic anhydrase 9, a potential intrinsic marker of hypoxia, is associated with poor prognosis in oesophageal squamous cell carcinoma
por: Tanaka, N, et al.
Publicado: (2008)

Overexpression of nucleostemin contributes to an advanced malignant phenotype and a poor prognosis in oral squamous cell carcinoma
por: Yoshida, R, et al.
Publicado: (2014)

MYC functions are specific in biological subtypes of breast cancer and confers resistance to endocrine therapy in luminal tumours
por: Green, Andrew R, et al.
Publicado: (2016)

Diagnostic values of soluble mesothelin-related peptides for malignant pleural mesothelioma: updated meta-analysis
por: Cui, Ai, et al.
Publicado: (2014)

High expression of Lin28 is associated with tumour aggressiveness and poor prognosis of patients in oesophagus cancer
por: Hamano, R, et al.
Publicado: (2012)

Cortactin expression predicts poor survival in laryngeal carcinoma
por: Gibcus, J H, et al.
Publicado: (2008)

Deregulation of MUC4 in gastric adenocarcinoma: potential pathobiological implication in poorly differentiated non-signet ring cell type gastric cancer
por: Senapati, S, et al.
Publicado: (2008)

Overexpression of PFTK1 predicts resistance to chemotherapy in patients with oesophageal squamous cell carcinoma
por: Miyagaki, H, et al.
Publicado: (2012)

Upregulated EMMPRIN/CD147 might contribute to growth and angiogenesis of gastric carcinoma: a good marker for local invasion and prognosis
por: Zheng, H-C, et al.
Publicado: (2006)

Overexpression of stathmin in oral squamous-cell carcinoma: correlation with tumour progression and poor prognosis
por: Kouzu, Y, et al.
Publicado: (2006)

Cytosolic phospholipase A2-α expression in breast cancer is associated with EGFR expression and correlates with an adverse prognosis in luminal tumours
por: Caiazza, F, et al.
Publicado: (2011)

Interleukin-6 released by colon cancer-associated fibroblasts is critical for tumour angiogenesis: anti-interleukin-6 receptor antibody suppressed angiogenesis and inhibited tumour–stroma interaction
por: Nagasaki, T, et al.
Publicado: (2014)

A loss of c-kit expression is associated with an advanced stage and poor prognosis in breast cancer
por: Tsutsui, S, et al.
Publicado: (2006)

Loss of imprinting of IGF2 correlates with hypermethylation of the H19 differentially methylated region in hepatoblastoma
por: Honda, S, et al.
Publicado: (2008)

Enhancement of osteoclastogenic activity in osteolytic prostate cancer cells by physical contact with osteoblasts
por: Shiirevnyamba, A, et al.
Publicado: (2011)

Neutrophils: driving progression and poor prognosis in hepatocellular carcinoma?
por: Margetts, Jane, et al.
Publicado: (2018)

Membranous expression of podocalyxin-like protein is an independent factor of poor prognosis in urothelial bladder cancer
por: Boman, K, et al.
Publicado: (2013)

Clinical significance of miR-144-ZFX axis in disseminated tumour cells in bone marrow in gastric cancer cases
por: Akiyoshi, S, et al.
Publicado: (2012)

FGFR2 gene amplification and clinicopathological features in gastric cancer
por: Matsumoto, K, et al.
Publicado: (2012)

Expression of Twist increases the risk for recurrence and for poor survival in epithelial ovarian carcinoma patients
por: Hosono, S, et al.
Publicado: (2007)

EpCAM expression varies significantly and is differentially associated with prognosis in the luminal B HER2(+), basal-like, and HER2 intrinsic subtypes of breast cancer
por: Soysal, S D, et al.
Publicado: (2013)

Serum 20S proteasome is elevated in patients with renal cell carcinoma and associated with poor prognosis
por: de Martino, M, et al.
Publicado: (2012)

Expression of AT1 and AT2 angiotensin receptors in astrocytomas is associated with poor prognosis
por: Arrieta, O, et al.
Publicado: (2008)

Oestrogen receptor-α contributes to the regulation of the hedgehog signalling pathway in ERα-positive gastric cancer
por: Kameda, C, et al.
Publicado: (2010)

Overexpression of PBK/TOPK relates to tumour malignant potential and poor outcome of gastric carcinoma
por: Ohashi, Takuma, et al.
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_qnr7bo3gsa65hjsvrh4sc73346